HR Execs on the Move

Dyax Corp.

www.dyax.com

 
Dyax Corp. (Dyax) is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million
  • www.dyax.com
  • 300 Technology Sq
    Cambridge, MA USA 02139-3515
  • Phone: 617.225.2500

Executives

Name Title Contact Details

Similar Companies

SynergenX Health

Reinvigorate your life for Low T, menopause symptoms, weight loss. Low-T & Hormone Treatment in Houston, Dallas, San Antonio, Texas and Chicago, Illinois, by licensed Testosterone and HRT treatment professionals.

Voyager HospiceCare Inc

Voyager HospiceCare Inc is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Turenne and Associates

Turenne & Associates is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Montgomery, AL. To find more information about Turenne & Associates, please visit www.turenneteam.com

KaloBios

KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.

Milan Laser

The largest laser hair removal company in Nebraska, Iowa, Colorado, Illinois, Kentucky, Kansas, Pennsylvania, New York, Indiana, Maine, Minnesota, North Dakota, South Dakota, Wisconsin, Tennessee, Michigan and Missouri.